Outlook Therapeutics OTLK
NASDAQ OTLK
$0.62 -0.01 (-1.31%)
As of: Sep 30, 2026 · 9:57 AM EDT

Outlook Therapeutics (OTLK) EBT Margin (2015 - 2025)

Updated

Outlook Therapeutics' EBT Margin came in at -4526.01% for FY2025 (year ended Sep 30, 2025).

Analysis

Outlook Therapeutics (OTLK) EBT Margin (2015 - 2025) Analysis & Trends

Going back to FY2015, Outlook Therapeutics' EBT Margin data covers 6 fiscal years.

  • The FY2025 figure represents the highest annual EBT Margin in data going back to FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Outlook Therapeutics 84.78 Mn 49.03 Mn -8,265.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,338.75%
Sep 30, 2019 -217.47%
Jun 30, 2019 -893.79%
Mar 31, 2019 -1,597.90%
Dec 31, 2018 -912.50%
Sep 30, 2018 -1,644.94%
Jun 30, 2018 -1,092.37%
Mar 31, 2018 -976.81%
Dec 31, 2017 -656.99%
Sep 30, 2017 -202.47%
Jun 30, 2017 -1,758.72%
Mar 31, 2017 -2,654.21%
Dec 31, 2016 -6,298.89%
Sep 30, 2016 -2,135.40%
Jun 30, 2016 -4,511.46%
Mar 31, 2016 -350.98%
Dec 31, 2015 -1,689.85%
Sep 30, 2015 -3,647.43%
Jun 30, 2015 -895.87%
Mar 31, 2015 -2,971.87%
API Access

Outlook Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=OTLK&period=max&api_key=YOUR_API_KEY